Setia Vishwas 4
4 · MapLight Therapeutics, Inc. · Filed Jan 29, 2026
Research Summary
AI-generated summary of this filing
MapLight (MPLT) CFO Setia Vishwas Withholds 33,382 Shares
What Happened Setia Vishwas, CFO of MapLight Therapeutics (MPLT), had 33,382 shares withheld on January 27, 2026 to satisfy tax withholding related to the settlement of a restricted stock unit (RSU) award. The withholding was recorded at $17.98 per share for a total value of approximately $600,208. This was a tax-withholding disposition (transaction code F), not an open-market sale.
Key Details
- Transaction date: 2026-01-27; filing date: 2026-01-29.
- Price per share: $17.98; shares withheld/disposed: 33,382; total value ≈ $600,208.
- Shares owned after transaction: not specified in the provided filing excerpt.
- Footnote: Shares withheld represent tax withholding on RSU settlement. The retained securities remain subject to a 180-day IPO lock-up tied to the October 26, 2025 final prospectus (lock-up through April 24, 2026).
- Timeliness: Filing was submitted two days after the transaction; no late-filing flag indicated in provided data.
Context This was a routine cashless tax withholding to satisfy RSU tax obligations rather than a voluntary open-market sale; such withholdings are common and do not by themselves indicate the insider's view on the company. The retained shares remain subject to the IPO lock-up, limiting transfers until the lock-up expires.
Insider Transaction Report
- Tax Payment
Voting Common Stock
[F1]2026-01-27$17.98/sh−33,382$600,208→ 387,819 total
Footnotes (1)
- [F1]Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of a restricted stock unit award. The securities of the Issuer retained by the Reporting Person remain subject to the terms a lock-up agreement entered into with the underwriters for the Issuer's initial public offering, pursuant to which the Reporting Person agreed, subject to certain exceptions, not to directly or indirectly sell or otherwise transfer securities of the Issuer for a period of 180 days following the date of the final prospectus relating to the initial public offering, which was October 26, 2025.